FDA Enforcement Class II Terminated

McKesson Cardiology Hemo, Release SW version 13.0. Used for physiological monitoring, image and data processing. McKesson Cardiology Hemo is intended for complete physiological/hemodynamic monitoring, clinical data acquisition, medical image and data processing, and analytical assessment. McKesson Cardiology Hemo is also intended for patient/procedural data management, such as documentation, logging, reporting, trending, storing, reviewing, carrying out clinical calculations and exporting various representations of the acquired data.

Recall: Z-2968-2018 · Reported September 12, 2018

Enforcement

Recall Number
Z-2968-2018
Event ID
80723
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
McKesson Israel Ltd.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
September 12, 2018
Initiation Date
March 12, 2018
Classification Date
August 31, 2018
Termination Date
November 23, 2021
Address
Or Towers Bldg. B, 4, Nehoshet St., Tel Aviv, N/A, N/A, Israel

Description

McKesson Cardiology Hemo, Release SW version 13.0. Used for physiological monitoring, image and data processing. McKesson Cardiology Hemo is intended for complete physiological/hemodynamic monitoring, clinical data acquisition, medical image and data processing, and analytical assessment. McKesson Cardiology Hemo is also intended for patient/procedural data management, such as documentation, logging, reporting, trending, storing, reviewing, carrying out clinical calculations and exporting various representations of the acquired data.

Reason

Change Healthcare has identified an issue where, under certain circumstances, the Real Time Monitor (RTM) may not display physiological signals.

Code Info

software versions: 13.0 HF1, 13.0HF2, 13.0HF3

Distribution

US Distribution to states of: CA, CO, CT, FL, GA, KS, IN, LA, NJ, NY, OK, OH, SC, and TX; and internationally to: UK.

Quantity

31 units